The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary

Drug and Alcohol Dependence

Volumn 100, Issue 3, 2009, Pages 240-247

  Gyarmathy, V Anna ^a   Neaigus, Alan ^b,c   Mitchell, Mary M ^d   Ujhelyi, Eszter ^e  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c Columbia University ^*  (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Szent Laszlo Hospital   (Hungary)

Author keywords

Central Europe; HCV infection; Minorities; One piece and two piece syringes; Syringe cleaning

Indexed keywords

ADULT; ARTICLE; CLEANING; CORRELATION ANALYSIS; DRUG ABUSE; FEMALE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUNGARY; INFECTION PREVENTION; INFECTION RISK; INJECTION DRUG USER; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONE PIECE SYRINGE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; SELF REPORT; SYRINGE; TWO PIECE SYRINGE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; FEMALE; HEPATITIS C; HUMANS; HUNGARY; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 58149378146     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.10.014     Document Type: Article

References (39)

1. Abdala N., Crowe M., Tolstov Y., and Heimer R. Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions. Subst. Use Misuse 39 (2004) 581-600
2. Abdala N., Gleghorn A.A., Carney J.M., and Heimer R. Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J. Acquir. Immune Defic. Syndr. 28 (2001) 487-494
3. Centers for Disease Control and Prevention. Use of bleach for disinfection of drug injection equipment. MMWR Morb. Mortal. Wkly. Rep. 42 (1993) 418-419
4. Centers for Disease Control and Prevention. Selecting, Evaluating, and Using Sharps Disposal Containers - DHHS (NIOSH) Publication No. 97-111 (1998), National Institute for Occupational Safety and Health, Atlanta, GA
5. Clatts M.C., Heimer R., Abdala N., Goldsamt L.A., Sotheran J.L., Anderson K.T., Gallo T.M., Hoffer L.D., Luciano P.A., and Kyriakides T. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. J. Acquir. Immune Defic. Syndr. 22 (1999) 194-199
6. Des Jarlais D.C., Perlis T., Arasteh K., Hagan H., Milliken J., Braine N., Yancovitz S., Mildvan D., Perlman D.C., Maslow C., and Friedman S.R. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J. Acquir. Immune Defic. Syndr. 35 (2004) 158-166
7. Desenclos J.C., Papaevangelou G., and Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. AIDS 7 (1993) 1371-1377
8. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe, end year report 2005 (2006), Institute de Veille Sanitaire, Saint Maurice
9. European Monitoring Centre for Drugs and Drug Addiction. Annual report on the state of the drugs problem in Europe 2006 (2006), Office for Official Publications of the European Communities, Luxembourg
10. Gaughwin M.D., Gowans E., Ali R., and Burrell C. Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS 5 (1991) 1025-1027
11. Golub E.T., Strathdee S.A., Bailey S.L., Hagan H., Latka M.H., Hudson S.M., and Garfein R.S. Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 91 Suppl. 1 (2007) S30-S38
12. Grund J.P., and Stern L.S. Residual blood in syringes: size and type of syringe are important. AIDS 5 (1991) 1532-1533
13. Gyarmathy V.A., and Neaigus A. Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection. J. Urban Health 82 (2005) iv101-iv112
14. Gyarmathy V.A., and Neaigus A. The effect of personal network exposure on injecting equipment sharing among Hungarian IDUs. Connections 15 (2006) 29-42
15. Gyarmathy V.A., Neaigus A., Miller M., Friedman S.R., and Des Jarlais D.C. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J. Acquir. Immune Defic. Syndr. 30 (2002) 448-456
16. Gyarmathy V.A., Neaigus A., Ujhelyi E., Szabó T., and Rácz J. Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors. Drug Alcohol Depend. 82 (2006) S65-S69
17. Gyarmathy V.A., Racz J., Neaigus A., and Ujhelyi E. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary. AIDS Educ. Prev. 16 (2004) 276-287
18. Gyarmathy V.A., Ujhelyi E., Neaigus, and A. HIV and selected blood-borne and sexually transmitted infections in a predominantly Roma (Gypsy) neighbourhood in Budapest, Hungary: a rapid assessment. Cent. Eur. J. Public Health 16 (2008) 124-127
19. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., and Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
20. Heimer R., Kinzly M.L., He H., and Abdala N. The effect of acids on the survival of HIV during drug injection. J. Acquir. Immune Defic. Syndr. 45 (2007) 144-150
21. Kapadia F., Latka M.H., Hagan H., Golub E.T., Campbell J.V., Coady M.H., Garfein R.S., Thomas D.L., Bonner S., Thiel T., and Strathdee S.A. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J. Urban Health 84 (2007) 99-115
22. Kapadia F., Vlahov D., Des Jarlais D.C., Strathdee S.A., Ouellet L., Kerndt P., Morse E.E.V., Williams I., Garfein R.S., and Second Collaborative Injection Drug User Study (CIDUS-II) Group. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?. Epidemiology 13 (2002) 738-741
23. Koester S., Glanz J., and Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 9 (2005) 27-39
24. Latka M.H., Metsch L.R., Mizuno Y., Tobin K., Mackenzie S., Arnsten J.H., and Gourevitch M.N. Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: role of personal and partnership influences. J. Acquir. Immune Defic. Syndr. 42 (2006) 222-228
25. Lithuanian AIDS Center, 2008. Outpatient Care Department. http://old.aids.lt/Care.php.
26. Lorvick J., Bluthenthal R.N., Scott A., Gilbert M.L., Riehman K.S., Anderson R.L., Flynn N.M., and Kral A.H. Secondary syringe exchange among users of 23 California syringe exchange programs. Subst. Use Misuse 41 (2006) 865-882
27. Metsch L.R., Pereyra M., Purcell D.W., Latkin C.A., Malow R., Gomez C.A., and Latka M.H. Correlates of lending needles/syringes among HIV-seropositive injection drug users. J. Acquir. Immune Defic. Syndr. 46 Suppl. 2 (2007) S72-S79
28. National Center for Epidemiology. HIV/AIDS situation in Hungary [in Hungarian]. Epinfo 7 (2007) 86-87
29. Neaigus A., Friedman S.R., Curtis R., Des Jarlais D.C., Furst R.T., Jose B., Mota P., Stepherson B., Sufian M., Ward T., and Wright J.W. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Social Sci. Med. 38 (1994) 67-78
30. Neaigus A., Gyarmathy V.A., Miller M., Frajzyngier V., Zhao M., Friedman S.R., and Jarlais D.C. Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend. 89 (2007) 234-243
31. Ompad D.C., Fuller C.M., Vlahov D., Thomas D., and Strathdee S.A. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin. Infect. Dis. 35 (2002) 783-788
32. Purcell D.W., Mizuno Y., Metsch L.R., Garfein R., Tobin K., Knight K., and Latka M.H. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J. Urban Health 83 (2006) 656-668
33. Rácz J., Gyarmathy V.A., Neaigus A., and Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 19 (2007) 59-66
34. Schlumberger M.G., Desenclos J.C., Papaevangelou G., Richardson S.C., and Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Eur. J. Epidemiol. 15 (1999) 207-215
35. Titus S., Marmor M., Des Jarlais D., Kim M., Wolfe H., and Beatrice S. Bleach use and HIV seroconversion among New York City injection drug users. J. Acquir. Immune Defic. Syndr. 7 (1994) 700-704
36. Topolánszky A. Jelentés a magyarországi kábítószerhelyzetro{combining double acute accent}l (2002), GYISM, Budapest
37. Ujhelyi, E., Tarjan, V., Szomor, K., Zacher, G., Szabo, J., Lepes, P., 1998. Prevalence of HIV, HBsAg, and HCV infection among Hungarian drug users. Int. Conf. AIDS abstract no. 60099.
38. Zule W.A., Desmond D.P., and Neff J.A. Syringe type and drug injector risk for HIV infection: a case study in Texas. Soc. Sci. Med. 55 (2002) 1103-1113
39. Zule W.A., Ticknor-Stellato K.M., Desmond D.P., and Vogtsberger K.N. Evaluation of needle and syringe combinations. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14 (1997) 294-295